期刊文献+

1例微小病变肾病伴急性肾损伤患者的药学监护

Pharmaceutical Care for One Patient with Minimal Change Disease and Acute Kidney Injury
原文传递
导出
摘要 目的探讨临床药师参与临床药物治疗中的工作模式、方法与作用。方法临床药师参与1例微小病变伴急性肾损伤患者的临床治疗过程,将患者的病理特点、临床症状、实验室相关检查与药物的作用特点、不良反应相结合,进行综合分析与评估,协助医师为患者制定个体化给药方案,并对患者进行用药教育与药学监护。结果临床药师通过参与临床药物治疗,提高了患者的依从性,优化了药物治疗方案,尽可能减少了药物不良反应的发生。结论临床药师利用药学专业知识融入临床工作,参与临床药物治疗,提高药物治疗效果,减少不良反应发生,为患者提供更好的药学服务,同时也为医师制定个体化治疗方案提供帮助,促进合理化用药。 OBJECTIVE To explore the working mode, method and role of clinical of pharmacists in the clinical treatment. METHODS Through participating in the treatment of a patient with minimal change disease and acute kidney injury, the clinical pharmacists combined the pathological features, clinical symptoms, laboratory examinations with the characteristics and adverse reactions of the drug to conduct a comprehensive analysis and evaluation. Then assisted clinicians to develop individualized drug therapy and carried out pharmaceutical care. RESULTS Clinical pharmacists involved in clinical medication, the patient medication compliance was improved, the drug treatment program was optimized, and the occurrence of adverse drug reactions was minimized. CONCLUSION Clinical pharmacists participated in the clinical drug treatment process by pharmaceutical professional knowledge, so as to improve the effect of drug treatment and reduce the drug reactions and provide better pharmacy services for patients, which can provide assistance for physicians to develop individualized treatment programs and promote rationalized medication.
作者 陈晨 王中奎 赵夕岚 唐崑 CHEN Chen;WANG Zhongkui;ZHAO Xilan;TANG Kun(Department of Pharmacology,General Hospital of Eastern Military Command of PLA,Nanjing 210002,China;Department of Pharmacy,China-Japan Friendship Hospital,Beijing 100029,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2020年第5期595-599,共5页 Chinese Journal of Modern Applied Pharmacy
基金 江苏省青年基金项目(BK20180292)。
关键词 微小病变 急性肾损伤 药学监护 minimal change disease acute kidney injury pharmaceutical care
  • 相关文献

参考文献5

二级参考文献47

  • 1章友康,姜筠,王海燕,王骏,邹万忠,潘缉圣.肾病综合征合并特发性急性肾功能衰竭10例分析[J].中华内科杂志,1995,34(3):157-160. 被引量:38
  • 2Jennette JC,Falk RJ.Adult minimal change glomerulopathy with acute renal failure[J]. Am J Kidney Dis,1990,16(5): 432-437.
  • 3Smith JD,Hayslett JP. Reversible renal failure in the nephrotic syndrome[J]. Am J Kidney Dis,1992,19(3):201-213.
  • 4Waldman M,Crew RJ,Valeri A,et al.Adult minimal-change disease: clinical characteristics, treatment, and outcomes [J].Clin J Am Soc Nephrol, 2007, 2(3): 445-453.
  • 5Vande WJ, Mauel R, Raes A, et al. ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane[J].Am J Kidney Dis, 2004, 43(3):399-404.
  • 6Lowenstein J,Schacht RG,Baldwin DS. Renal failure in minimal change nephrotic syndrome[J].Am J Med,1981,70(2): 227-233.
  • 7Chen CL,Fang HC,Chou KJ,et al.Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure[J].Am J Kidney Dis,2005,45(5):818-825.
  • 8中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南.中国骨质疏松和骨矿物盐疾病杂志,2011,4: 2-17.
  • 9NIH Consensus Development Panel on Osteoporosis Prevention,Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, andtherapy. JAMA, 2001,285: 785-795.
  • 10Compston JE. Management of glucocorticoid-induced osteoporosis,Nat Rev Rheumatol, 2010,6: 82-88.

共引文献352

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部